戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r and PC death) are likely to be primary and degenerative.
2 d 5% organic mitral regurgitation [OMR] [62% degenerative]).
3 ents with severe MR of various etiologies (4 degenerative, 4 functional, and 2 mixed) were treated.
4 rvational study including primary repairs of degenerative AAAs in the Netherlands between 2016 and 20
5  stress response, has critical influences on degenerative aging in humans.
6 ific effects of aging within LCs or reflects degenerative alterations to the wider supporting microen
7 c dysfunction in epilepsy and in an array of degenerative and autoimmune diseases of the central nerv
8  valve stenosis is an increasingly prevalent degenerative and inflammatory disease.
9         After ischemic injury, a multiphasic degenerative and inflammatory response is coupled with s
10 te immune system is activated in a number of degenerative and inflammatory retinal disorders such as
11 sponses and synaptic dysfunction in multiple degenerative and neuropsychiatric brain disorders.
12                     The role of microglia in degenerative and regenerative processes after damage of
13 ells of the CNS, and invading macrophages in degenerative and regenerative processes after injury are
14 ypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways u
15 lecule p75(NTR) modulator that downregulates degenerative and upregulates trophic receptor-associated
16  diseases, the majority of which are severe, degenerative, and not currently treatable or preventable
17 sease from genetically mediated or acquired (degenerative) aortopathy remains a challenging clinical
18 : Pulmonary arterial hypertension (PAH) is a degenerative arteriopathy that leads to right ventricula
19  potential clinical use for the treatment of degenerative, autoimmune diseases and for organ transpla
20 date for vision restoration in patients with degenerative blinding diseases.
21 caused by functional alterations rather than degenerative brain disease or another structural lesion.
22                Alzheimer's disease (AD) is a degenerative brain disease that destroys memory and othe
23 al populations with intellectual disability, degenerative brain disease, brain injury, psychiatric di
24 ve the specificity of diagnoses of prodromal degenerative brain disease.
25 countries, from rheumatic heart disease to a degenerative calcific pathogenesis.
26  a novel mechanistic framework in the axonal degenerative cascade for therapeutic interventions in a
27  bounded by the nuclear membrane, containing degenerative cell organelles and heterolysosomes (type1)
28                                              Degenerative cerebellar ataxias (DCAs) affect up to 1 in
29 ovel strategy for treating motor symptoms of degenerative cerebellar ataxias.
30 ne expression for modeling developmental and degenerative cerebellar disorders.
31 l knockout of Ttbk2 in adult mice results in degenerative cerebellar phenotypes that recapitulate asp
32 d promising in patients with non-myelopathic degenerative cervical cord compression (NMDCCC), i.e., w
33 rd injury - the most common form of which is degenerative cervical myelopathy (DCM) - have provided i
34             Patients with moderate-to-severe degenerative cervical myelopathy aged 18-80 years, who h
35                                              Degenerative cervical myelopathy represents the most com
36 atients undergoing decompression surgery for degenerative cervical myelopathy.
37  surgery in patients with moderate-to-severe degenerative cervical myelopathy.
38       Reversible addition-fragmentation type degenerative chain transfer contributes to the narrow di
39 ortive therapeutic agent to reduce the early degenerative changes and possible hypertrophic remodelin
40 t is linked to disease severity and specific degenerative changes in the cerebellum.
41 ignificant pain, disability, and progressive degenerative changes in the knee joint that lead to oste
42  in glucose metabolism, which led to chronic degenerative changes in the outer retina of these mice.
43 be a factor in the precocious development of degenerative changes in the temporomandibular joint (TMJ
44   Mankin scores showed significantly greater degenerative changes in the TMJs of 3- and 10-mo-old Ddr
45 fections, and myelokathexis, which describes degenerative changes of mature neutrophils and hyperplas
46 eration as evidenced by urothelial thinning, degenerative changes such as intracellular vacuole forma
47 cales; these scales are insensitive to early degenerative changes that underlie disease progression.
48                     A higher severity of BLB degenerative changes was associated with a higher degree
49                            No DDR2-dependent degenerative changes were seen in knees.
50 ith similar clinical presentation, including degenerative changes, infection, and insufficiency and p
51     Both injected cohorts showed gliosis and degenerative changes, though ERG responses were minimall
52 racrine effects protecting chondrocytes from degenerative changes.
53 way could further our understanding of other degenerative choroidopathies, such as geographic atrophy
54 ruits could contribute to reduce the risk of degenerative chronic diseases due to their bioactive pro
55 ial in the postnatal brain, with progressive degenerative ciliary and behavioral phenotypes; and they
56                     Osteoarthritis (OA) is a degenerative condition caused by dysregulation of multip
57 ogliosis is associated with normal aging and degenerative conditions such as Alzheimer's disease (AD)
58 ted in the cell death that underlies several degenerative conditions(2), and induction of ferroptosis
59 for 250 genetic diseases, many metabolic and degenerative conditions, and forms of cancer that are an
60 a's involvement in early-stage apoptosis and degenerative conditions, tracking the dynamics of mitoch
61  which include autoimmune, inflammatory, and degenerative conditions.
62  approach that may have efficacy in multiple degenerative conditions.
63 ciated brain changes in AD and other chronic degenerative conditions.
64 ern indeed also was observed in traumatic or degenerative conditions.
65 ngivalis may link these two inflammatory and degenerative conditions.
66 s and cerebellum, which frequently follows a degenerative course.
67 ervous system (CNS), causing the adult-onset degenerative disease amyotrophic lateral sclerosis (ALS)
68 ysregulated RNP granules drive neuromuscular degenerative disease but have not previously been linked
69 ystrophy (DMD) is an X-linked, lethal muscle degenerative disease caused by loss of dystrophin protei
70 muscular dystrophy (DMD) is a lethal, muscle degenerative disease causing premature death of affected
71 ve Rab prenylation in a model of the retinal degenerative disease choroideremia.
72 e sclerosis (MS), a chronic inflammatory and degenerative disease of the CNS, and in its mouse model,
73 00), genetically complex and multifactorial, degenerative disease of the cornea whose pathogenesis an
74 dibular joint (TMJ) osteoarthritis (OA) is a degenerative disease of the joint that can produce persi
75 eber hereditary optic neuropathy (LHON) is a degenerative disease of the optic nerve associated with
76                     Osteoarthritis (OA) is a degenerative disease resulting in irreversible, progress
77            Retinitis pigmentosa is a retinal degenerative disease that leads to blindness through pho
78 bjects with RPE65 mutation-associated IRD, a degenerative disease that progresses to complete blindne
79 city occurs during progressive photoreceptor degenerative disease to help maintain normal visual beha
80 itis pigmentosa (RP) is an inherited retinal degenerative disease with severe vision impairment leadi
81 cated independently in lifespan, ageing, and degenerative disease(6,12-14)-are thus mechanistically c
82 sult successively in diabetes, neuromuscular degenerative disease, and perinatal lethality.
83 acic aortic aneurysms have been labeled as a degenerative disease, characterized by alterations in ex
84 mains that model ER membranes, cause an axon degenerative disease, hereditary spastic paraplegia (HSP
85 nherited and largely incurable photoreceptor degenerative disease, is unclear.
86 ularly in brain, is thought to contribute to degenerative disease, post-developmental interventions t
87             In the subgroup of patients with degenerative disease, the mean repair rate was 67% (n =
88 -i.e., selective cell-loss paradigms akin to degenerative disease-are less well defined.
89  shares a characteristic gene signature with degenerative disease-associated microglia (DAM).
90  animal models of retinal injury and retinal degenerative disease.
91 toreceptor cells in a mouse model of retinal degenerative disease.
92 modulatory therapeutic approaches to retinal degenerative disease.
93 eral sclerosis (ALS) is a fatal motor neuron degenerative disease.
94  estimate disability of patients with spinal degenerative disease.
95 sistent visual function during photoreceptor degenerative disease.
96 ishing them from osteoarthritis, a primarily degenerative disease.
97 rable potential for the treatment of retinal degenerative disease.
98  cancer therapy and its malfunction causes a degenerative disease.
99 odevelopmental component and is not solely a degenerative disease.
100  for being repurposed to treat photoreceptor degenerative disease.SIGNIFICANCE STATEMENT Photorecepto
101             In contrast to inherited retinal degenerative diseases (e.g., RP), typically leading to a
102  the pathological cell death associated with degenerative diseases (i.e., Alzheimer's, Huntington's,
103 to the development of chronic autoimmune and degenerative diseases and cancer.
104 ic cell death process-is involved in various degenerative diseases and represents a targetable suscep
105                                      Retinal degenerative diseases are the leading causes of blindnes
106 ctive drug target for the treatment of neuro-degenerative diseases as well as for brain and spinal co
107 er disparity in the development and types of degenerative diseases as well as highlighting a wide ran
108 progressive damage that may create different degenerative diseases at a later age.
109  show that micro-EI stimulation could affect degenerative diseases based on inflammation, implicating
110            Inherited and age-related retinal degenerative diseases cause progressive loss of rod and
111                                      Retinal degenerative diseases caused by photoreceptor cell death
112 ention and management of several chronic and degenerative diseases including cancer, cardiovascular d
113 MX inhibition might be useful for preventing degenerative diseases involving ferroptosis.
114 ce of vascular inflammation to major retinal degenerative diseases is unresolved.
115 for the treatment and prevention of blinding degenerative diseases like retinitis pigmentosa and age-
116                             The existence of degenerative diseases linked to lamin A mutations sugges
117                  Wider implications are that degenerative diseases may need to be treated differently
118  study brain and spinal cord inflammation in degenerative diseases of the CNS such as multiple sclero
119  RP is very similar to that of other retinal degenerative diseases such as age-related macular degene
120  defects observed after traumatic injury, in degenerative diseases such as glaucoma, or in compressiv
121               Recent work in musculoskeletal degenerative diseases such as osteoarthritis have reveal
122 n ciliopathies, a group of developmental and degenerative diseases that affect almost all organs and
123 ulticellular organisms, a critical driver of degenerative diseases, and can be harnessed for treating
124 its in organelle transport typical of axonal degenerative diseases, and these deficits were worsened
125 ing a central if not primary role in retinal degenerative diseases, and this association should be a
126 therapy for mitral regurgitation (MR) due to degenerative diseases, but information on late outcomes
127 ases, including inherited genetic disorders, degenerative diseases, inflammation, and cancer, has fue
128 ated with aging and with pathologies such as degenerative diseases, metabolic and inflammatory disord
129                              In many retinal degenerative diseases, photoreceptor neurons die by apop
130 explore their therapeutic potential in neuro-degenerative diseases, such as Alzheimer's and Parkinson
131 earning and memory and may be compromised in degenerative diseases, such as Alzheimer's disease.
132                                Outer retinal degenerative diseases, such as retinitis pigmentosa (RP)
133 n or morphogenesis leads to blinding retinal degenerative diseases, the majority of which have a gene
134 l of prosthetics for restorative function in degenerative diseases, trauma and amputation; and even a
135                                  The retinal degenerative diseases, which together constitute a leadi
136  major challenge in the treatment of retinal degenerative diseases, with the transplantation of repla
137 e significant prophylactic value for retinal degenerative diseases.
138 ticity as a treatment for diabetes and other degenerative diseases.
139 1, has been linked to both developmental and degenerative diseases.
140 on-malignant cells in the setting of chronic degenerative diseases.
141 licating the relevance of LE to cone/macular degenerative diseases.
142 e in the pathophysiology of human cancer and degenerative diseases.
143 y, and genetic testing for inherited retinal degenerative diseases.
144 umatic injuries and drug targets for chronic degenerative diseases.
145 ntribute to cancer and many inflammatory and degenerative diseases.
146 erstanding of the early pathology of retinal degenerative diseases.
147  and implicate the pathway as a modulator of degenerative diseases.
148  may link the pathogeneses of these two cell-degenerative diseases.
149 ay important roles in human inflammatory and degenerative diseases.
150 esenting new therapeutic promise for retinal degenerative diseases.
151 e stress response and may contribute to some degenerative diseases.
152 s cancer, diabetes, autoimmune disorders and degenerative diseases.
153  protein aggregates, a hallmark of aging and degenerative diseases.
154 on, autoimmune, inflammatory, metabolic, and degenerative diseases.
155 function plays a significant role in retinal degenerative diseases.
156 ssociated with decreased risk of chronic and degenerative diseases.
157 the ER, is induced in several age-associated degenerative diseases.
158 r halting the progression of several retinal degenerative diseases.
159 ation as a means to treat human injuries and degenerative diseases.
160 therapies to restore retinal neurons lost to degenerative diseases.
161  could have a prophylactic value for retinal degenerative diseases.
162 he cholesterol accumulation in NPC and other degenerative diseases.
163 dical history included hypertension, asthma, degenerative disk disease, and migraine, all of which we
164 T Huntington's disease (HD) is a progressive degenerative disorder caused by aberrant trinucleotide e
165 trophic lateral sclerosis is the most common degenerative disorder of motor neurons in adults.
166 ryngeal Neuropathy (RLN), a highly prevalent degenerative disorder of the RLn in horses that predomin
167     Amyotrophic lateral sclerosis (ALS) is a degenerative disorder that is characterized by loss of m
168 on's disease (HD) is a progressive and fatal degenerative disorder that results in debilitating cogni
169 undus Dystrophy (SFD), an inherited, macular degenerative disorder, caused by mutations in the Tissue
170 he mechanisms by which E2 contributes to TMJ degenerative disorders and the reasons for its targeted
171 1 gene have been identified to cause retinal degenerative disorders generally known as bestrophinopat
172 eponderance of temporomandibular joint (TMJ) degenerative disorders in women and their early onset du
173                      Mutations in LMNA cause degenerative disorders including the premature aging dis
174                       LMNA mutations lead to degenerative disorders known as laminopathies, including
175  to both wild-type p97 and mutants linked to degenerative disorders known as multisystem proteinopath
176  mRNA can be used to treat monogenic retinal degenerative disorders of the RPE.
177 ve stem-cell-based treatments in genetic and degenerative disorders or severe injuries, the number of
178 -based therapies for the treatment of muscle degenerative disorders should not only regenerate fibers
179  in the development of various age-dependent degenerative disorders such as cancer, neurodegeneration
180 e a heterogeneous group of developmental and degenerative disorders that affect motor unit function.
181 l practice and form a heterogeneous group of degenerative disorders that are classified either as pur
182                      Leigh syndrome embodies degenerative disorders with a collection of symptoms sec
183 is of macular degeneration and other related degenerative disorders, and the normal functions of Vn,
184 ous group of upper and/or lower motor neuron degenerative disorders, in which the particular clinical
185 ch may further lead to develop various neuro-degenerative disorders.
186 nt of the MitCHAP-60 and SPG13 neuromuscular degenerative disorders.
187 ly susceptible to premature death in retinal degenerative disorders.
188 3 in preventing or delaying the onset of the degenerative effects in a mouse model of osteoarthritis.
189 or the lifespan of the fly and block the pro-degenerative effects of activated dSarm in vivo.
190 spinal cord injury (SCI) causes a cascade of degenerative events including cell death, axonal damage,
191 age leads to a rapidly escalating cascade of degenerative events, known as secondary injury.
192 MTP18 expression suppression during CNS axon degenerative events.
193                                              Degenerative, eyewall-parallel fissure planes and their
194 is regulated via the opposing actions of pro-degenerative factors such as SARM1 and a MAPK signal and
195 om four unrelated families manifesting a non-degenerative form of PCH.
196 CRISPR)/Cas9 gene editing can knock down pro-degenerative genes in RGCs and provide effective neuropr
197                 Two types of GSG: Viable and Degenerative GSG were defined.
198  a proof-of-concept study, a model involving degenerative inflamed human annulus fibrosus (hAF) cells
199                      Multiple sclerosis is a degenerative inflammatory disease of the CNS characteris
200 tination, perturb mitochondria, and initiate degenerative inflammatory responses that resemble sporad
201 t alternative to BM-MSC to potentially treat degenerative/inflammatory joint diseases.
202  has previously been exclusively linked with degenerative IRD.
203 bular joint (TMJ) disc displacement (DD) and degenerative joint disease (DJD) has never been conclusi
204                   Osteoarthritis is a common degenerative joint disease for which no disease-modifyin
205 teoarthritis (OA) is the most common chronic degenerative joint disease which causes substantial join
206                     Osteoarthritis (OA) is a degenerative joint disease, and inflammation within an a
207              Osteoarthritis (OA) is a common degenerative joint disease, characterized by cartilage l
208  avoiding the evolution of this condition to degenerative joint disease.
209  pathological decrease of the lubrication in degenerative joint disease.
210 of SnCs as a therapeutic target for treating degenerative joint disease.
211           Such changes might mimic prevalent degenerative joint diseases in the elderly.
212       Osteoarthritis (OA) is the most common degenerative joint disorder.
213 onic low back pain represent the most common degenerative joint pathologies and are leading causes of
214 yopic subjects, based on the presence of any degenerative lesion secondary to myopia.
215 key role in the rosette formation during the degenerative loss of CE.
216 sequestered and degraded by mitophagy during degenerative loss of post-mitotic cells of ocular tissue
217                                   Hence, pro-degenerative MAPK signaling functions upstream of SARM1
218 o systematically investigate homeostatic and degenerative mechanisms associated with the TMJ disc.
219 lity of the C9-500 animals for understanding degenerative mechanisms, we validated and established tw
220 gesting the involvement of similar secondary degenerative mechanisms.
221 ried and 5,475 patients were identified with degenerative mitral disease who underwent mitral valve o
222 nsider atrial fibrillation (AF) complicating degenerative mitral regurgitation (DMR) a debated indica
223       Left atrial enlargement is frequent in degenerative mitral regurgitation (DMR), but its link to
224 r study, 30 consecutive patients with severe degenerative mitral regurgitation (MR) were treated with
225               One hundred four patients with degenerative mitral regurgitation surgically amenable to
226                          Among patients with degenerative mitral regurgitation with a flail leaflet r
227  outcome after MV repair and replacement for degenerative mitral regurgitation with a flail leaflet.
228 as associated with increased repair rates of degenerative mitral valve disease (adjusted odds ratio [
229  years, 47% women) consecutive patients with degenerative mitral valve disease, in whom LAVI was pros
230 ated the influence of surgeon case volume on degenerative mitral valve repair rates and outcomes.
231  with total annual mitral volumes of >50 and degenerative mitral valve repair rates of >70%, compared
232 els to distinguish the temporal sequences of degenerative molecular processes from other variability
233 c lateral sclerosis (ALS) is a heterogeneous degenerative motor neuron disease linked to numerous gen
234 stment for confounders, job strain predicted degenerative MSDs among women after 4 and 11 years of fo
235 g aging breaks muscle homeostasis and causes degenerative muscle disease by irreversibly dampening sa
236 tial therapeutic target for aging-associated degenerative muscle disease.
237 is thought to arise from the accumulation of degenerative mutations during the sustained co-evolution
238 erstanding of the etiopathogenesis of canine degenerative myelopathy.
239 dismutase 1 (SOD1) is associated with canine degenerative myelopathy: the only naturally occurring la
240 t DUX4 + myonuclei, evoke a slow progressive degenerative myopathy.
241 lation results in features characteristic of degenerative neuro-axonal dystrophy, including abnormall
242 -length effect on expression can be found in degenerative neurological illnesses, such as Alzheimer's
243                RTX application did not cause degenerative or ultrastructural changes in the treated n
244 e those with symptomatic, severe functional, degenerative, or mixed mitral regurgitation deemed at hi
245          Although the basic mechanism of its degenerative pathogenesis remains poorly understood, a s
246 lf be risk factor for accelerating spread of degenerative pathology.
247  for the field since it identifies a defined degenerative pathway involved in axonal degeneration in
248  protected neurons by suppressing both known degenerative pathways and a new pathway involving unliga
249 mutant HTT activates DNA damage-response pro-degenerative pathways and impairs transcription, trigger
250 elated phenotypes and suggests APOE4-related degenerative pathways contributing to AD pathogenesis.
251 ever, whether functional specialization is a degenerative phenomenon unique to sex chromosomes, or if
252  physiologic and inevitable, skin aging is a degenerative phenomenon whereby both intrinsic and envir
253  then demonstrate that pHERV-W ENV induces a degenerative phenotype in microglial cells, driving them
254  Short telomere syndromes have a predominant degenerative phenotype marked by organ failure that most
255 function, leading to a dramatic multi-system degenerative phenotype resembling premature aging.
256 ll molecules targeting alphaSyn reverted the degenerative phenotype under both basal and induced stre
257 CFH knockout (Cfh(-/-)) with an aged retinal degenerative phenotype.
258 s, while ConeDeltaBsg mice did not display a degenerative phenotype.
259 egation, a process that appears to drive the degenerative phenotypes in amyloidosis patients.
260 f another NMD gene UPF2 also ameliorated the degenerative phenotypes in dipeptide repeat-expressing f
261 iral reverse transcriptase activity prevents degenerative phenotypes observed in fly and rat neurons.
262 ional expression of Nmnat after the onset of degenerative phenotypes significantly delays the progres
263 ows significant symptomatic overlap with non-degenerative primary psychiatric disorders including maj
264 with retinal development, in Tvrm4 mice, the degenerative process can be induced after retinal develo
265                                          The degenerative process involves inflammation and a remarka
266 have occurred either as a consequence of the degenerative process or of a pre-morbid trait.
267               However, their role during the degenerative process remains poorly understood.
268                                  Ageing is a degenerative process that leads to tissue dysfunction an
269 mine neuronal vulnerability early during the degenerative process to gain insight into key events und
270 re thought to be critically involved in this degenerative process.
271 interacting substrate protein attenuates the degenerative process.
272  to be tailored to the specific stage in the degenerative process.
273  used to facilitate the understanding of the degenerative process.
274 follow a developmental, maturational, and/or degenerative process.
275 lopment in Wolfram syndrome, with additional degenerative processes in both white and gray matter.
276 hanges in diffusivity that are indicative of degenerative processes in the primary visual pathway com
277 anded rod opsin, which in excess accelerates degenerative processes in the retina.
278  autoimmune disease driving inflammatory and degenerative processes that damage the central nervous s
279 resulting in robust activation of these cell degenerative processes, and a concomitant increase in mu
280  and mechanistic links among these three pro-degenerative processes.
281 , in particular pathological, neurovascular, degenerative processes.
282 gies for reversing cell loss associated with degenerative retinal conditions.
283 T Retinitis pigmentosa (RP) is an inherited, degenerative retinal disease that leads to blindness for
284 asia type 2; MacTel) is a rare neurovascular degenerative retinal disease.
285 ing and highlighted the potential for curing degenerative retinal diseases from intrinsic cellular so
286                                              Degenerative retinal diseases such as retinitis pigmento
287 ical trials investigating new treatments for degenerative retinal diseases.
288 g visual function in patients suffering from degenerative retinal diseases.
289 ss of photoreceptors is a common endpoint in degenerative retinal diseases.
290 hich has therapeutic effects against certain degenerative retinal diseases.
291 ormity in adults are iatrogenic flatback and degenerative scoliosis.
292 ating in preservation of mitochondria in the degenerative setting.
293 ults support the existence of an interaxonal degenerative signal that promotes catastrophic degenerat
294 ion, a well known model of DLK-dependent pro-degenerative signaling.
295 e-zipper kinase (DLK) conveys retrograde pro-degenerative signals to neuronal cell bodies via its dow
296  that chronic GENUS shifts neurons to a less degenerative state, improving synaptic function, enhanci
297 thy mammalian retina, macrophages in retinal degenerative states are not solely comprised of microgli
298 , ligamentous injuries, common traumatic and degenerative tendon pathology, abnormalities of transver
299 pairment and/or late neurological disorders, degenerative tissue effects including circulatory and he
300 ronic heart failure, prior endocarditis, and degenerative valve disease; and had higher median age-ad

 
Page Top